Stockreport

RXi Pharmaceuticals Announces Pricing Of $15 Million Upsized Underwritten Public Offering

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com
PDF MARLBOROUGH, Mass., Oct. 1, 2018 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company developing the next generation of immuno-onco [Read more]